medigraphic.com
ISSN 1995-9494 (Electronic)
Revista del Hospital Clínico Quirúrgico "Arnaldo Milián Castro"

2022, Number 1

<< Back Next >>

Acta Med Cent 2022; 16 (1)

Enfermedad de Kikuchi-Fujimoto y COVID-19. Informe de caso

Reyes HDL, Ravelo IE, Artiles MD

Language: Spanish
References: 14
Page: 150-157
PDF size: 397.09 Kb.


ABSTRACT

Introduction: Kikuchi-Fujimoto disease is considered a necrotizing histiocytic lymphadenitis of infrequent presentation. Its diagnosis is anatomopathological. In the current global context of the COVID-19 pandemic, this viral disease ranges from an asymptomatic condition to severe pneumonia, in addition to other atypical presentations.
Patient information: white female, 34 years old, with health history and no toxic habits, who presented with fever between 38 and 390C, once or twice a day, without chills, which decreased with the administration of antipyretics. After the first 13 days of the onset of symptoms, the fever disappeared for six days and then reappeared with the same characteristics; for this reason it was decided to admit her to the hospital. The diagnosis of Kikuchi-Fujimoto disease was obtained after several complementary tests.
Conclusions: the report of this case could announce the possible location of the new SARS-CoV-2 coronavirus among the etiologies of EKF.


REFERENCES

  1. Aguado Navarro M, Sagristá González M. Linfadenitis histiocítica necrotizante o enfermedad de Kikuchi-Fujimoto. Med Fam Andal [Internet]. 2018 [citado 18/09/2021];19(2):180-181. Disponible en: https://www.samfyc.es/wp-content/uploads/2019/01/v19n2_10_cartaLinfadenitis.pdf

  2. Singh JM, Shermetaro CB. Kikuchi-Fujimoto disease in Michigan: a rare case report and review of the literature. Clin Med Insights Ear Nose Throat [Internet]. 2019 [citado 18/09/2021];12:1179550619828680. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6393831/. https://dx.doi.org/10.1177/1179550619828680

  3. Joean O, Thiele T, Raap M, Schmidt RE, Stoll M. Take a second look: it’s Kikuchi’s disease! A case report and review of literature. Clin Pract [Internet]. 2018 [citado 18/09/2021];8(4):1095. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6297864/. https://dx.doi.org/10.4081/cp.2018.1095

  4. Almeida Esquivel Y, Piñón García K, Creagh García J. Enfermedad de Kikuchi-Fujimoto. Rev Ciencias Médicas [Internet]. 2021 Jul-Ago [citado 27/09/2021];25(1):e4563. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1561-31942021000100020

  5. Lugo López JI, Garduño Mejía JE, Hernández Nava M. Enfermedad de Kikuchi-Fujimoto (linfadenitis histiocítica necrosante). Caso clínico más revisión bibliográfica. Rev Mex Cir Bucal Maxilofac [Internet]. 2019 [citado 27/09/2021];15(1):5-12. Disponible en: https://www.medigraphic.com/cgi-bin/new/resumen.cgi?IDARTICULO=86141

  6. Jaseb K, Nameh Goshay Fard N, Rezaei N, Sadeghian S, Sadeghian S. COVID-19 in a case with Kikuchi-Fujimoto disease. Clin Case Rep [Internet]. 2021 [citado 18/09/2021];9(3):1279-1282. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7981657/. https://dx.doi.org/10.1002/ccr3.3748

  7. Racette SD, Alexiev BA, Angarone MP, Bhasin A, Lima K, Jennings LJ, et al. Kikuchi-Fujimoto disease presenting in a patient with SARS-CoV-2: a case report. BMC Infect Dis [Internet]. 2021 [citado 18/09/2021];21(1):740. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8329643/. https://dx.doi.org/10.1186/s12879-021-06048-0

  8. Capó de Paz V, Borrajero Martínez I, Montero González T, Hurtado de Mendoza Amat J, de Armas Rodríguez Y, Domínguez Alvarez C. Hallazgos de autopsias de 50 fallecidos con SARS-CoV-2 en Cuba entre abril y septiembre de 2020. Anales de la ACC [Internet]. 2021 [citado 20/09/2021];11(2):e860. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S2304-01062021000200024

  9. Comino-Trinidad O, Calvo A, Ojeda A, Mercadal J, Cornellas L, Ferrando C. Coagulación intravascular diseminada como forma de presentación de la enfermedad por coronavirus-19. Caso clínico. Rev Esp Anestesiol Reanim [Internet]. 2021 [citado 21/09/2021];68(1):41-45. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7247485/. https://dx.doi.org/10.1016/j.redar.2020.05.010

  10. Asuar Geisselmann I, Martínez Torre S, Gómez Molinero I, Morales Calahorro E, Larumbe Milla S. Formas atípicas de presentación de la enfermedad COVID-19 observadas en atención primaria. FMC [Internet]. 2020 [citado 21/09/2021];27(9):469-475. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7682426/. https://dx.doi.org/10.1016/j.fmc.2020.06.002

  11. Gil R, Bitar P, Deza C, Dreyse J, Florenzano M, Ibarra C, et al. Cuadro Clínico del COVID-19. Rev Méd Clín Las Condes [Internet]. 2021 [citado 21/09/2021];32(1):20-29. Disponible en: https://www.elsevier.es/es-revista-revista-medica-clinica-las-condes-202-articulo-cuadro-clinico-del-covid-19-S0716864020300912. http://doi.org/10.1016/j.rmclc.2020.11.004

  12. González González F, Cortés Correa C, Penaranda Contreras E. Manifestaciones cutáneas en pacientes con COVID-19: características clínicas y mecanismos fisiopatológicos postulados. Actas Dermosifiliogr [Internet]. 2021 [citado 27/09/2021];112(4):314-23. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7698822/. https://dx.doi.org/10.1016/j.ad.2020.11.013

  13. Sánchez Linares V, Nieda Rosales L, Martínez Cuervo J. Manifestaciones cutáneas de Covid-19. Gac Méd Espirituana [Internet]. 2020 [citado 27/09/2021];22(3):18-26. Disponible en: http://revgmespirituana.sld.cu/index.php/gme/article/view/2201/pdf

  14. Ministerio de Salud Pública de Cuba. Protocolo de manejo clínico de COVID-19: versión 1.6 Ferbrero) [Internet]. La Habana: MINSAP; 2021 [citado 27/09/2021]. Disponible en: https://covid19cubadata.github.io/protocolos/protocolo-version-6.pdf




2020     |     www.medigraphic.com